Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance

This cohort study examines whether hydroxyurea use changes in young adults with sickle cell disease who are transitioning from pediatric to adult health care.

Detalles Bibliográficos
Autores principales: Mathias, Joacy G., Nolan, Vikki G., Klesges, Lisa M., Badawy, Sherif M., Cooper, William O., Hankins, Jane S., Smeltzer, Matthew P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515209/
https://www.ncbi.nlm.nih.gov/pubmed/34643722
http://dx.doi.org/10.1001/jamanetworkopen.2021.28971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515209/
https://www.ncbi.nlm.nih.gov/pubmed/34643722
http://dx.doi.org/10.1001/jamanetworkopen.2021.28971

Ejemplares similares